leisure time -WSS

leisure time

author：Wikipedia 2025-09-02 08:22:42 - browse：2

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Biotech venture capitalists face new demands from investors

hotspot

WSS

Test for long Covid? Researchers find new clue in blood samples

Eli Lilly, Pfizer, and others want in on the online prescription market

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

EU regulator recommends expanding Mounjaro approval to obesity

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

focus

leisure time

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Sports medicine is finally prioritizing gender equality

Readout Newsletter: Merck, Vertex, and Viking updates

Alkermes shareholders re

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Activists slam private health insurers over coverage restrictions

Abortion pill Supreme Court ruling could impact entire drug industry

focus

Decaf coffee targeted by food safety group under obscure FDA rule

Abortion pill Supreme Court ruling could impact entire drug industry

States should stop sabotaging methadone treatment reform

Elizabeth Holmes banned from government health programs

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Dewpoint Therapeutics lays off staff after losing partnerships

Wikipedia

hotspot

explore

hotspot